서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 40 of 64

Issue DateTitle / Author(s) / CitationFileAltmetrics
2011-01
Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01)
DOI
2011-05
Exaggeration of Wrinkles after Botulinum Toxin Injection for Forehead Horizontal Lines
DOI
2011-09
What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label study

Shim, Geumsook; Park, Hye Youn; Jang, Joon Hwan; Kim, Euitae; Park, Hye Yoon; Hwang, Jae Yeon; Kim, Sung Nyun; Jang, Go-Eun; Kwon, Jun Soo

International Clinical Psychopharmacology, Vol.26 No.5, pp.284-290

DOI
2013-03
Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
DOI
2014-06
The Influence of Pain Sensitivity on the Treatment Outcome of Transforaminal Epidural Steroid Injection in Patients with Lumbar Spinal Stenosis
DOI
2014-08
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial
DOI
2015-03
Treatment for unresectable gastric cancer

Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue

대한의사협회지, Vol.58 No.3, pp.209-215

DOI
2015-10
Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer
DOI
2015-11
The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer
2016-03
A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)
DOI
2016-08
Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial
DOI
2016-11
TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials
DOI
2017-02
The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis
DOI
2017-04
Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042)
DOI
2017-05
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma The METGastric Randomized Clinical Trial
DOI
2017-06
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial
DOI
2017-07
Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
DOI
2017-07
Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer

Song, Su Jeong; Min, Ji; Suh, Sung Yun; Jung, Sun Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun

Supportive Care in Cancer, Vol.25 No.7, pp.2241-2248

DOI
2017-10
Efficacy of sequential ipilimumab monotherapy versus best supportive care for unresectable locally advanced/metastatic gastric or gastroesophageal junction cancer
DOI
2017-12
Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis
DOI
2017-12
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies
DOI
2018-03
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases
DOI
2018-05
Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial
DOI
2018-05
Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives
DOI
2018-07
Effects of epidural steroid injections on bone mineral density and bone turnover markers in patients taking anti-osteoporotic medications

Nah, Seon Yoon; Lee, Jae Hyup; Lee, Ji-Ho

Pain Physician, Vol.21 No.4, pp.E435-E447

view file
2018-07
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): A randomised, open-label, controlled, phase 3 trial
DOI
2018-08
Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3
DOI
2018-11
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study)
DOI
2018-12
Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study

Kim, Sang Yun; Kim, Young Kyun; Yun, Pil Young; Bae, Ji Hyun

Maxillofacial Plastic and Reconstructive Surgery, Vol.40 No.1, p. 21

DOI
2019-02
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
DOI
2019-07
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): Study protocol for a randomized controlled trial
DOI
2019-08
Epidemiology of pharmaceutically treated depression and treatment resistant depression in South Korea
DOI
2019-09
Nonsurgical treatments for patients with radicular pain from lumbosacral disc herniation
view fileDOI
2019-09
Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis

Choi, Kyomin; Hong, Yoon-Ho; Ahn, So-Hyun; Baek, Seot-Hee; Kim, Jun-Soon; Shin, Je-Young; Sung, Jung-Joon

Therapeutic Advances in Neurological Disorders, Vol.12

DOI
2019-10
The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab
DOI
2019-12
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): A multicentre, open-label, randomised, phase 2 trial
DOI
2020-01
The Hemodynamic Effect of Epinephrine-Containing Local Infiltration Analgesia After Tourniquet Deflation During Total Knee Arthroplasty: A Retrospective Observational Study

Yoo, Seokha; Chung, Jae-Yeon; Ro, Du Hyun; Han, Hyuk-Soo; Lee, Myung Chul; Kim, Jin-Tae

Journal of Arthroplasty, Vol.35 No.1, pp.76-81

DOI
2020-02
PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation

Min, Ahrum; Im, Seock-Ah

Cancers, Vol.12 No.2, p. 394

DOI
2020-02
TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy
view fileDOI
2020-02
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
DOI
1 2